Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hisashi Hashimoto

Showing results (101-110 of 108) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 108 results.
Tuberculosis (Edinburgh, Scotland)|September 21, 2020
Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in JapanSeigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto, et al.
FEBS Letters|June 2, 2009
A murine model of neonatal diabetes mellitus in Glis3-deficient miceNaoki Watanabe, Kentaro Hiramatsu, Rieko Miyamoto, et al.
Thoracic Cancer|September 7, 2020
MicroRNA-200b is a potential biomarker of the expression of PD-L1 in patients with lung cancerSeigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto, et al.
Plos Genetics|April 5, 2014
Sox5 functions as a fate switch in medaka pigment cell developmentYusuke Nagao, Takao Suzuki, Atsushi Shimizu, et al.
Cancer Discovery|November 20, 2025
Spatial multiomic analyses reveal carcinogenic pathways in end-stage renal diseaseJun Takahashi, Yosuke Tanaka, Yusuke Sato, et al.
Current Biology : CB|March 6, 2012
The medaka zic1/zic4 mutant provides molecular insights into teleost caudal fin evolutionYuuta Moriyama, Toru Kawanishi, Ryohei Nakamura, et al.
Thoracic Cancer|June 5, 2020
Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trialNobuaki Kobayashi, Hisashi Hashimoto, Chisato Kamimaki, et al.
Plos One|July 18, 2009
Polycystic kidney disease in the medaka (Oryzias latipes) pc mutant caused by a mutation in the Gli-Similar3 (glis3) geneHisashi Hashimoto, Rieko Miyamoto, Naoki Watanabe, et al.
Pageof 11

Showing results (101-110 of 108) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 108 results.
Tuberculosis (Edinburgh, Scotland)|September 21, 2020
Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in JapanSeigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto, et al.
FEBS Letters|June 2, 2009
A murine model of neonatal diabetes mellitus in Glis3-deficient miceNaoki Watanabe, Kentaro Hiramatsu, Rieko Miyamoto, et al.
Thoracic Cancer|September 7, 2020
MicroRNA-200b is a potential biomarker of the expression of PD-L1 in patients with lung cancerSeigo Katakura, Nobuaki Kobayashi, Hisashi Hashimoto, et al.
Plos Genetics|April 5, 2014
Sox5 functions as a fate switch in medaka pigment cell developmentYusuke Nagao, Takao Suzuki, Atsushi Shimizu, et al.
Cancer Discovery|November 20, 2025
Spatial multiomic analyses reveal carcinogenic pathways in end-stage renal diseaseJun Takahashi, Yosuke Tanaka, Yusuke Sato, et al.
Current Biology : CB|March 6, 2012
The medaka zic1/zic4 mutant provides molecular insights into teleost caudal fin evolutionYuuta Moriyama, Toru Kawanishi, Ryohei Nakamura, et al.
Thoracic Cancer|June 5, 2020
Afatinib + bevacizumab combination therapy in EGFR-mutant NSCLC patients with osimertinib resistance: Protocol of an open-label, phase II, multicenter, single-arm trialNobuaki Kobayashi, Hisashi Hashimoto, Chisato Kamimaki, et al.
Plos One|July 18, 2009
Polycystic kidney disease in the medaka (Oryzias latipes) pc mutant caused by a mutation in the Gli-Similar3 (glis3) geneHisashi Hashimoto, Rieko Miyamoto, Naoki Watanabe, et al.
Pageof 11